Learn / ABUS
NASDAQ: ABUS
Arbutus Biopharma (ABUS) stock, explained like you're 5
Arbutus Biopharma trades on the Nasdaq under the ticker ABUS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 647 million dollars.
- Ticker
- ABUS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 647 million dollars
Is Arbutus Biopharma a small, medium or large cap company?
No. Arbutus Biopharma is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 647 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Arbutus Biopharma makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ABUS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- ABUS Stock On Track For Best Day In About Two Months What’s The Moderna Connection? (Stocktwits)
- Arbutus Biopharma shares jump after unveiling $230 million share buyback plan (Yahoo Finance)
- ABUS Stock Price, Quote & Chart (ChartMill)
- ABUS Stock Surges 10% Today What’s Driving This Super Rally? (TradingView)
- Arbutus Biopharma (ABUS) Stock Profit Surge Leaves Durability Questions Open (Simply Wall Street)
Follow ABUS in your daily brief
Each trading day at 5 PM ET we post what happened to Arbutus Biopharma and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ABUS
Questions about Arbutus Biopharma stock
What does Arbutus Biopharma do?
Arbutus Biopharma trades on the Nasdaq under the ticker ABUS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 647 million dollars.
What is the ticker symbol for Arbutus Biopharma?
Arbutus Biopharma trades under the ticker ABUS on the Nasdaq.
What is Arbutus Biopharma's market cap?
Arbutus Biopharma is a small cap stock with a market cap of about 647 million dollars.
How does Arbutus Biopharma make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ABUS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ABUS stock every day?
Add ABUS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.